{
    "code": "52027647",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027647",
    "time": "2019-12-27 03:44:24",
    "許可證字號": "衛部藥輸字第027647號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/04\/30",
    "發證日期": "108\/04\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202764705",
    "中文品名": "泰息安膠囊50毫克",
    "英文品名": "Tasigna Capsules 50mg",
    "適應症": "1. 新確診之慢性期費城染色體陽性的慢性骨髓性白血病成年及兒童病人。\r\n2. 具抗藥性或耐受性不良之慢性期或加速期費城染色體陽性的慢性骨髓細胞白血病成年病人。\r\n3. 具抗藥性或耐受性不良之慢性期費城染色體陽性的慢性骨髓細胞白血病兒童病人。",
    "劑型": "130膠囊劑",
    "包裝": "4-1000粒PVC\/PVDC鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "新療效(新適應症)",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013001920",
            "成分名稱": "NILOTINIB HYDROCHLORIDE MONOHYDRATE",
            "含量描述": "(equivalent to 50mg nilotinib anhydrous free base)",
            "含量": "55.1500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tasigna 50mg_LFT_TWI-170619_C-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027647&Seq=001&Type=9"
        },
        {
            "title": "Tasigna 50mg_Foil-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027647&Seq=003&Type=8"
        },
        {
            "title": "Tasigan 50mg_FB_120 Caps-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027647&Seq=002&Type=8"
        },
        {
            "title": "Tasigan 50mg_FB_40 Caps-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027647&Seq=001&Type=8"
        }
    ]
}